Nalaganje...
One year of complete clinical response in a metastatic breast cancer patient treated with a combination of lapatinib and gemcitabine
The treatment of metastatic breast cancer is challenging. We recently assisted in the development of targeted therapies (in combination with chemotherapy or as monotherapy) that have improved results for selected groups of patients. Lapatinib is a dual tyrosine kinase inhibitor that has shown effica...
Shranjeno v:
| Main Authors: | , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Multimed Inc.
2010
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2854642/ https://ncbi.nlm.nih.gov/pubmed/20404981 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|